Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis

Stopped early · Phase 3

Conditions studied: Cystic Fibrosis

In brief

This is an open-label extension study for participants who completed a Phase 3, placebo-controlled study of ataluren in participants with nonsense mutation cystic fibrosis (nmCF) not receiving chronic inhaled aminoglycosides.

Key facts

Study ID
NCT02456103
Run by
PTC Therapeutics
People needed
246
Starts
2015-08-31
Expected to finish
2017-06-02
Last updated by the study team
2020-04-27

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.